ArticleFrontiers in oncology2025

Development and external validation of a prognostic nomogram for event-free survival in resectable non-small cell lung cancer after neoadjuvant chemoimmunotherapy.

Linlin Qu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.